Ermenegildo Zegna NV
ZGN
DexCom
DXCM
New Fortress Energy
NFE
Workday
WDAY
eBay
EBAY
US Stock MarketDetailed Quotes
REPL Replimune
- 12.490
- +0.480+4.00%
Close Dec 20 16:00 ET
- 12.490
- 0.0000.00%
Post 20:01 ET
941.00MMarket Cap-4.11P/E (TTM)
13.040High11.430Low2.35MVolume11.780Open12.010Pre Close29.54MTurnover4.65%Turnover RatioLossP/E (Static)75.34MShares17.00052wk High2.52P/B630.96MFloat Cap4.92052wk Low--Dividend TTM50.52MShs Float54.850Historical High--Div YieldTTM13.41%Amplitude4.920Historical Low12.567Avg Price1Lot Size
About Replimune Company
Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.
Company Profile
SymbolREPL
Company NameReplimune
Listing DateJul 20, 2018
Issue Price15.00
Founded2017
CEODr. Sushil Patel, PhD
MarketNASDAQ
Employees331
Fiscal Year Ends03-31
Address500 Unicorn Park Drive,Suite 303,3rd Floor
CityWoburn
ProvinceMassachusetts
CountryUnited States of America
Zip Code01801
Phone1-781-222-9600
Websitehttp://www.replimune.com
Company Executives
- Name
- Position
- Salary
- Dr. Sushil Patel, PhD
- Director and Chief Executive Officer
- --
- Andrew Schwendenman
- Chief Accounting Officer
- --
- Emily Hill
- Chief Financial Officer
- 3.38M
- Dr. Konstantinos Xynos, M.D.
- Chief Medical Officer
- 2.45M
- Christopher Sarchi
- Chief Commercial Officer
- --
- Paul Bullock
- Chief Manufacturing Officer
- --
- Philip Astley-Sparke
- Executive Chairman of the Board
- 6.02M
- Veleka Peeples-Dyer
- Independent Director
- 667.97K
- Madhavan Balachandran
- Independent Director
- --
- Joseph P. Slattery, C.P.A.
- Independent Director
- 362.60K
- Christy J. Oliger
- Independent Director
- 352.60K
- Paolo Pucci
- Independent Director
- 360.10K
- Dieter Weinand
- Lead Independent Director
- 516.81K
- Dr. Kapil Dhingra, M.B.B.S.
- Independent Director
- 357.60K